19th January 2022|News, Scientific Media LPLDL® from ProBiotix Health showcases statistically significant reductions in multiple coronary heart disease biomarkers in hypercholesterolemic adults
18th January 2022|Investor Media, News Paul Cannings appointed Head of Operations & Quality at OptiBiotix
22nd October 2021|Investor Media, News OptiBiotix leads sector with surging half year interim sales figures
14th October 2021|Commercial Media, News SlimBiome® from OptiBiotix takes Weight Maintenance top spot in Nutrition Industry Executive 2021 Awards
4th October 2021|Commercial Media, News OptiBiotix targets healthy snacking market with launch of high fibre fruit gummies featuring WellBiome®
16th August 2021|Commercial Media, News ProBiotix Health CholBiome®X3 shortlisted for second consecutive year in NutraIngredients Asia 2021 Awards
19th July 2021|Commercial Media, News ProBiotix enters exclusive South Korean distribution deal for CholBiome®
